A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

US Food and Drug Administration Commissioner Dr. Marty Makary suggested in a new interview that autism is caused by a range ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other ...

One of the FDA’s recently departed top officials is ... though all signs point to it being Peter Marks, M.D., Ph.D., who announced his departure as head of the CBER in late March.

Kelly asked Makary about Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, who was forced out last month. Marks, who had been instrumental in ...

Former CBER head Peter Marks says he blocked RFK Jr. from vaccine safety database before leaving FDA: AP While the situation may seem dire, the industry and lawmakers can still act before things ...

Senior Correspondent Dr. Peter Marks is the kind of health official both Democrats and Republicans used to admire. He served in the U.S. Food and Drug Administration (FDA) for 13 years ...

Key leadership departures—like former FDA Chief Medical Officer Hilary Marston, M.D., and the agency’s former Center for Biologics Evaluation and Research director Peter Marks, M.D., Ph.D ...